|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosner I, Bratslavsky G, Pinto PA and
Linehan WM: The clinical implications of the genetics of renal cell
carcinoma. Urol Oncol. 27:131–136. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Novara G, Ficarra V, Antonelli A, Artibani
W, Bertini R, Carini M, Cunico S Cosciani, Imbimbo C, Longo N, et
al: Validation of the 2009 TNM version in a large
multi-institutional cohort of patients treated for renal cell
carcinoma: Are further improvements needed? Eur Urol. 58:588–595.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Barrett T, Troup DB, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, et al: NCBI GEO: Archive for functional genomics data
sets-10 years on. Nucleic Acids Res. 39(Database Issue):
D1005–D1010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parkinson H, Kapushesky M, Shojatalab M,
Abeygunawardena N, Coulson R, Farne A, Holloway E, Kolesnykov N,
Lilja P, Lukk M, et al: ArrayExpress-a public database of
microarray experiments and gene expression profiles. Nucleic Acids
Res. 35(Database issue): D747–D750. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ni D, Ma X, Li HZ, Gao Y, Li XT, Zhang Y,
Ai Q, Zhang P, Song EL, Huang QB, et al: Downregulation of FOXO3a
promotes tumor metastasis and is associated with metastasis-free
survival of patients with clear cell renal cell carcinoma. Clin
Cancer Res. 20:1779–1790. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Mestas J, Burdick MD, Reckamp K, Pantuck
A, Figlin RA and Strieter RM: The role of CXCR2/CXCR2 ligand
biological axis in renal cell carcinoma. J Immunol. 175:5351–5357.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tölle A, Jung M, Lein M, Johannsen M,
Miller K, Moch H, Jung K and Kristiansen G: Brain-type and
liver-type fatty acid-binding proteins: New tumor markers for renal
cancer? BMC Cancer. 9:2482009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang ML and Zhou ZH: A k-nearest neighbor
based algorithm for multi-label classification. Journal. 2:718–721.
2005.
|
|
10
|
Gautier L, Cope L, Bolstad BM and Irizarry
RA: affy-analysis of Affymetrix GeneChip data at the probe level.
Bioinformatics. 20:307–315. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Rao Y, Lee Y, Jarjoura D, Ruppert AS, Liu
CG, Hsu JC and Hagan JP: A comparison of normalization techniques
for microRNA microarray data. Stat Appl Genet Mol Biol. 7::
2008.PubMed/NCBI
|
|
12
|
Gentleman R, Carey VJ, Huber W, Irizarry
RA and Dudoit S: Bioinformatics and computational biology solutions
using R and Bioconductor. Springer; 2005, View Article : Google Scholar
|
|
13
|
Genovese C and Wasserman L: Operating
characteristics and extensions of the false discovery rate
procedure. J Royal Statistical Soci Series B (Statistical
Methodology). 64:499–517. 2002. View Article : Google Scholar
|
|
14
|
Ester M, Kriegel HP, Sander J and Xu X: A
density-based algorithm for discovering clusters in large spatial
databases with noise. Journal. 96:226–231. 1996.
|
|
15
|
Kolde R: Pheatmap: Pretty Heatmaps. R
Package Version 0.6.1. Journal. 2012.
|
|
16
|
Szekely GJ and Rizzo ML: Hierarchical
clustering via joint between-within distances: Extending Ward's
minimum variance method. J Classification. 22:151–183. 2005.
View Article : Google Scholar
|
|
17
|
Deza MM and Deza E: Encyclopedia of
Distances. Springer; 2009, View Article : Google Scholar
|
|
18
|
Dahlquist KD, Salomonis N, Vranizan K,
Lawlor SC and Conklin BR: GenMAPP, a new tool for viewing and
analyzing microarray data on biological pathways. Nat Genet.
31:19–20. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Doniger SW, Salomonis N, Dahlquist KD,
Vranizan K, Lawlor SC and Conklin BR: MAPPFinder: Using gene
ontology and GenMAPP to create a global gene-expression profile
from microarray data. Genome Biol. 4:R72003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Szklarczyk D, Franceschini A, Kuhn M,
Simonovic M, Roth A, Minguez P, Doerks T, Stark M, Muller J, Bork
P, et al: The STRING database in 2011: Functional interaction
networks of proteins, globally integrated and scored. Nucleic Acids
Res. 39(Database issue): D561–D568. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Smoot ME, Ono K, Ruscheinski J, Wang PL
and Ideker T: Cytoscape 2.8: New features for data integration and
network visualization. Bioinformatics. 27:431–432. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lamb J: The Connectivity Map: A new tool
for biomedical research. Nat Rev Cancer. 7:54–60. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lamb J, Crawford ED, Peck D, Modell JW,
Blat IC, Wrobel MJ, Lerner J, Brunet JP, Subramanian A, Ross KN, et
al: The connectivity map: Using gene-expression signatures to
connect small molecules, genes and disease. Science. 313:1929–1935.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Reddy KB, Nabha SM and Atanaskova N: Role
of MAP kinase in tumor progression and invasion. Cancer Metastasis
Rev. 22:395–403. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chaturvedi MM, Sung B, Yadav VR, Kannappan
R and Aggarwal BB: NF-κB addiction and its role in cancer: ‘One
size does not fit all’. Oncogene. 30:1615–1630. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Pu X, Shi M, Chen L, Song Y, Qian
L, Yuan G, Zhang H, Yu M, Hu M, et al: Critical role of c-Jun
overexpression in liver metastasis of human breast cancer xenograft
model. BMC Cancer. 7:1452007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Davis FM, Stewart TA, Thompson EW and
Monteith GR: Targeting EMT in cancer: Opportunities for
pharmacological intervention. Trends Pharmacol Sci. 35:479–488.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Tun HW, Marlow LA, Von Roemeling CA,
Cooper SJ, Kreinest P, Wu K, Luxon BA, Sinha M, Anastasiadis PZ and
Copland JA: Pathway signature and cellular differentiation in clear
cell renal cell carcinoma. PLoS One. 5:e106962010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Mikami S, Mizuno R, Kosaka T, Saya H, Oya
M and Okada Y: Expression of TNF-α and CD44 is implicated in poor
prognosis, cancer cell invasion, metastasis and resistance to the
sunitinib treatment in clear cell renal cell carcinomas. Int J
Cancer. 136:1504–1514. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wheeler AP and Ridley AJ: RhoB affects
macrophage adhesion, integrin expression and migration. Exp Cell
Res. 313:3505–3516. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hutchison N, Hendry BM and Sharpe CC: Rho
isoforms have distinct and specific functions in the process of
epithelial to mesenchymal transition in renal proximal tubular
cells. Cell Signal. 21:1522–1531. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang D, Ding Y, Luo WM, Bender S, Qian
CN, Kort E, Zhang ZF, VandenBeldt K, Duesbery NS, Resau JH and Teh
BT: Inhibition of MAPK kinase signaling pathways suppressed renal
cell carcinoma growth and angiogenesis in vivo. Cancer Res.
68:81–88. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Pei L, Castrillo A and Tontonoz P:
Regulation of macrophage inflammatory gene expression by the orphan
nuclear receptor Nur77. Mol Endocrinol. 20:786–794. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhou F, Drabsch Y, Dekker TJ, de Vinuesa
AG, Li Y, Hawinkels LJ, Sheppard KA, Goumans MJ, Luwor RB, de Vries
CJ, et al: Nuclear receptor NR4A1 promotes breast cancer invasion
and metastasis by activating TGF-β signalling. Nat Commun.
5:33882014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Westbrook L, Johnson AC, Regner KR,
Williams JM, Mattson DL, Kyle PB, Henegar JR and Garrett MR:
Genetic susceptibility and loss of Nr4a1 enhances
macrophage-mediated renal injury in CKD. J Am Soc Nephrol.
25:2499–2510. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Janda E, Lehmann K, Killisch I, Jechlinger
M, Herzig M, Downward J, Beug H and Grünert S: Ras and TGF[beta]
cooperatively regulate epithelial cell plasticity and metastasis
Dissection of Ras signaling pathways. J Cell Biol. 156:299–313.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Heldin C-H, Vanlandewijck M and Moustakas
A: Regulation of EMT by TGFβ in cancer. FEBS Lett. 586:1959–1970.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hohenester E and Yurchenco PD: Laminins in
basement membrane assembly. Cell Adh Migr. 7:56–63. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Patarroyo M, Tryggvason K and Virtanen I:
Laminin isoforms in tumor invasion, angiogenesis and metastasis.
Semin Cancer Biol. 12:197–207. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Vainionpää N, Lehto VP, Tryggvason K and
Virtanen I: Alpha4 chain laminins are widely expressed in renal
cell carcinomas and have a de-adhesive function. Lab Invest.
87:780–791. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Rogers TB, Inesi G, Wade R and Lederer W:
Use of thapsigargin to study Ca2+ homeostasis in cardiac cells.
Biosci Rep. 15:341–349. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Denmeade SR, Jakobsen CM, Janssen S, Khan
SR, Garrett ES, Lilja H, Christensen SB and Isaacs JT:
Prostate-specific antigen-activated thapsigargin prodrug as
targeted therapy for prostate cancer. J Natl Cancer Inst.
95:990–1000. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Doan NT, Paulsen ES, Sehgal P, Møller JV,
Nissen P, Denmeade SR, Isaacs JT, Dionne CA and Christensen SB:
Targeting thapsigargin towards tumors. Steroids. 2014.PubMed/NCBI
|
